Drug Name: Defencath
Active Ingredient: taurolidine, heparin
Indication: To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter (Catheter Lock Solution).
Approval Date: 11/15/2023
Company: CorMedix Inc
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214520s000lbl.pdf